Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Losec MUPS 20mg gastro-resistant tablets
0103050P0BBAEAN
|
Losec | Omeprazole | Gastro-Intestinal System | 7,020 |
|
Indoramin 20mg tablets
0704010M0AAAAAA
|
Indoramin | Indoramin | Obstetrics, Gynaecology and Urinary-Tract Disorders | 7,013 |
|
Zaluron XL 200mg tablets
0402010ABBHACAW
|
Zaluron XL | Quetiapine | Central Nervous System | 7,005 |
|
Beclometasone 200microg/Formoterol 6microg/dose dry pdr inh
0302000C0AACACA
|
Beclometasone dipropionate (Inhalation) | Beclometasone dipropionate | Respiratory System | 6,988 |
|
VIZhyal 0.2% eye drops preservative free
21300000931
|
VIZhyal 0.2% eye drops preservative free | Eye Products | Appliances | 6,987 |
|
Liquid paraffin light 63.4% bath additive
1302011L0AAAIAI
|
Light liquid paraffin | Light liquid paraffin | Skin | 6,981 |
|
Aymes Actagain Juce liquid (5 flavours)
0913011M0BBABAE
|
Aymes ready to serve 1.5 kcal/ml juice style | Ready to serve 1.5 kcal/ml juice style (0913011) | Nutrition and Blood | 6,978 |
|
Fentanyl 37.5microgram/hour transdermal patches
0407020A0AABWBW
|
Fentanyl | Fentanyl | Central Nervous System | 6,959 |
|
Madopar 100mg/25mg dispersible tablets
0409010K0BBALAL
|
Madopar | Co-beneldopa (Benserazide/levodopa) | Central Nervous System | 6,957 |
|
Isotard 40XL tablets
0206010K0BWABAG
|
Isotard | Isosorbide mononitrate | Cardiovascular System | 6,953 |
|
Ivermectin 3mg tablets
0505060I0AAACAC
|
Ivermectin | Ivermectin | Infections | 6,938 |
|
Eflornithine 11.5% cream
1309000X0AAAAAA
|
Eflornithine monohydrate chloride | Eflornithine monohydrate chloride | Skin | 6,920 |
|
Reboxetine 4mg tablets
0403040U0AAAAAA
|
Reboxetine | Reboxetine | Central Nervous System | 6,913 |
|
Tafluprost 15microg/Timolol 5mg/ml eye dps 0.3ml
1106000AMAAAAAA
|
Tafluprost and timolol | Tafluprost and timolol | Eye | 6,904 |
|
Calogen Extra Shots emulsion (2 flavours)
0913141B0BCAAAB
|
Calogen RtS 3.3 - 4 kcal/ml energy with protein liquid | RtS 3.3 - 4 kcal/ml energy with protein liquid (0913141) | Nutrition and Blood | 6,903 |
|
Fluoxetine 20mg/5ml oral solution sugar free
0403030E0AAAHAH
|
Fluoxetine hydrochloride | Fluoxetine hydrochloride | Central Nervous System | 6,889 |
|
Ocufresh Carbomer 0.2% lubricating eye gel
21300000701
|
Ocufresh Carbomer 0.2% lubricating eye gel | Eye Products | Appliances | 6,888 |
|
4SURE hypodermic insulin needles for pre-filled / reusable pen injectors screw on 4mm/31gauge
21010900938
|
4SURE hypodermic insulin needles for pre-filled / reusable pen injectors screw on 4mm/31gauge | Other Appliances | Appliances | 6,881 |
|
TriCare hypodermic insulin needles for pre-filled / reusable pen injectors screw on 6mm/31gauge
21010900623
|
TriCare hypodermic insulin needles for pre-filled / reusable pen injectors screw on 6mm/31gauge | Other Appliances | Appliances | 6,881 |
|
Acular 0.5% eye drops
110802070BBAAAA
|
Acular | Ketorolac trometamol | Eye | 6,876 |
|
Oxypro 30mg modified-release tablets
0407020ADBSAEAR
|
Oxypro | Oxycodone hydrochloride | Central Nervous System | 6,870 |
|
Sterile dressing pack specification 10
20030100150
|
Sterile dressing pack specification 10 | Wound Management & Other Dressings | Dressings | 6,868 |
|
Mini-Wright peak flow meter low range
21120000131
|
Mini-Wright peak flow meter low range | Peak Flow Meters | Appliances | 6,853 |
|
Compression hosiery class II below knee stocking circular knit made to measure
21070510180
|
Compression hosiery class II below knee stocking circular knit made to measure | Elastic Hosiery | Appliances | 6,846 |
|
Tetralysal 300 capsules
0501030L0BBABAB
|
Tetralysal | Lymecycline | Infections | 6,826 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.